Relx Plc $RELX Stock Position Lifted by American Century Companies Inc.

American Century Companies Inc. grew its holdings in shares of Relx Plc (NYSE:RELX) by 15.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 533,992 shares of the technology company’s stock after purchasing an additional 71,515 shares during the period. American Century Companies Inc.’s holdings in Relx were worth $25,504,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Salomon & Ludwin LLC grew its position in Relx by 1,646.2% in the 3rd quarter. Salomon & Ludwin LLC now owns 681 shares of the technology company’s stock valued at $32,000 after buying an additional 642 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Relx by 191.7% during the 3rd quarter. Nisa Investment Advisors LLC now owns 700 shares of the technology company’s stock worth $33,000 after buying an additional 460 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new stake in shares of Relx during the 2nd quarter worth about $38,000. Bessemer Group Inc. lifted its stake in shares of Relx by 104.2% in the 3rd quarter. Bessemer Group Inc. now owns 868 shares of the technology company’s stock worth $42,000 after acquiring an additional 443 shares during the period. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Relx in the 2nd quarter worth approximately $44,000. Institutional investors and hedge funds own 15.02% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on RELX. Citigroup began coverage on shares of Relx in a research note on Monday, January 12th. They set a “neutral” rating on the stock. Deutsche Bank Aktiengesellschaft upgraded Relx from a “hold” rating to a “buy” rating in a research report on Tuesday, December 9th. Zacks Research cut Relx from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of Relx in a research note on Monday, December 29th. Finally, Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a report on Saturday. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Relx Stock Up 1.5%

NYSE RELX opened at $35.72 on Monday. The company has a current ratio of 0.49, a quick ratio of 0.44 and a debt-to-equity ratio of 2.38. The company’s 50 day simple moving average is $36.16 and its 200 day simple moving average is $41.26. Relx Plc has a 12 month low of $27.57 and a 12 month high of $56.33.

Relx (NYSE:RELX) last announced its earnings results on Thursday, February 12th. The technology company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.85 by ($0.42). The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $6.70 billion. As a group, equities research analysts anticipate that Relx Plc will post 1.68 EPS for the current year.

Relx Dividend Announcement

The company also recently disclosed a dividend, which will be paid on Wednesday, June 24th. Investors of record on Friday, May 8th will be paid a $0.6559 dividend. The ex-dividend date of this dividend is Friday, May 8th. This represents a yield of 422.0%.

Relx Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.